Catalog excerpts
C€ ABOUT YZY MED Founded in 2011, with personalized diagnosis and treatment of cardiovascular, tumor as the strategic direction, Wuhan YZY Medical Science and Technology Co., Ltd. (YZY Med)is a high-tech enterprise specializing in the R&D, production and sales of individualized medical diagnostic products. The company has established various technical platforms, including ARMS fluorescence quantitative PCR, multiple fluorescence quantitative PCR, nucleic acid mass spectrometry, fluorescence in situ hybridization(FISH) and circulating tumor cell(CTC) detection, etc. Meanwhile, the self-developed products include molecular diagnostic products to guide personalized medicine for cardiovascular and cerebrovascular diseases, companion diagnostic products to guide tumor diagnosis and treatment, FISH products and circulating tumor cell (CTC) Autoanalyzer System, all these provide clinical diagnosis basis for precision medicine. The company has successfully developed over 160 genetic diagnostic products and multiple in vitro diagnostic (IVD) devices, among which 14 molecular diagnostic kits have been approved by the NMPA Class III medical device registration and approval, 110 products have obtained CE certification by the European Union. JKRanked First in Domestic Market of Molecular Diagnostics for PGx ^Complete Target Certificates for CDx Detection Kits JKThe First Autoanalyzer System on CTC Certified in China ■KComplete and Customizable FISH Probes with CE Certificates WUHAN YZY MEDICAL SCIENCE AND TECHNOLOGY CO.,LTD. Address: 4th & 5th floor. Unit 1, Building 23, Phase 1& 2 , Wuhan Optics Valley International Bio-pharmaceutical Enterprise Accelerator, 388 Gaoxin 2nd Road, Optics Valley, East Lake Hi-Tech Development Zone, Wuhan, Hubei, R.R.China 430075 Tel: 400-8013-133 Email: info@yzymedical.com Website: www.yzymed.com THE RIGHT DRUG FOR THE RIGHT PATIENT
Open the catalog to page 1THE RIGHT DRUG FOR THE RIGHT PATIENT THE RIGHT DRUG FOR THE RIGHT PATIENT | PRODUCT INTRODUCTION Targeted drugs are playing an increasingly important role in the treatment of advanced cancer patients,with the advantages of high efficiency, strong pertinence and low side effects. Compared with chemotherapeutic drugs, targeted drugs can significantly improve patients' quality of life to prolong their survival period. They have been used more and more widely in clinical application, some of them have entered the front-line clinical medication. EGFR, EML4-ALK, ROS1, KRAS, BRAF, NRAS, PIK3CA...
Open the catalog to page 2